Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Antibody-dependent cell-mediated cytotoxicity, Cancer research, Trastuzumab, Chemokine, Innate lymphoid cell, and Biology.
TOWARDS DAILY ONLINE MR-IMAGE-GUIDED PARTICLE THERAPY: FIRST CLINICAL APPLICATION OF A SHUTTLE-BASED WORKFLOW AT THE HEIDELBERG ION-BEAM THERAPY CENTER
Data from The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>
The Chemokine CX3CL1 Improves Trastuzumab Efficacy in HER2 Low–Expressing Cancer <i>In Vitro</i> and <i>In Vivo</i>
Das Chemokin CX3CL1 erhöht die Immuninfiltration, reduziert Tumorwachstum und -metastasierung und verbessert die Trastuzumab-Therapie in vitro und in vivo
Card9‐dependent IL‐1β regulates IL‐22 production from group 3 innate lymphoid cells and promotes colitis‐associated cancer